Vizconde, Ehreiz Raiden C.

BSN2-A

DRUG STUDY

Name of the Patient : Mrs. Anderson Age : 28yrs. Old Sex : Female Name of Student: Vizconde, Ehreiz Raiden C.
Civil Status : Married Religion : ______________Rm/Bed No. _________________ Area : __________________________ Level/ Block : 2-A
Address : _________________________________________________________________ Date Submitted : July 02,2022
Date of Admission : _____________________ Diagnosis : Left and Right Tubal Pregnancy Rating : ___________________________________________________

MEDICATION Classification/ Action Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities

Generic name: Classification: 1st Parenteral Hypersensitivity to Allergic reactions Stevens-Johnson Standard Procedure:
Cefazolin generation antibiotics, Prophylaxis of surgical cephalosporins. Confusion syndrome; 1. Introduce self to
Cephalosporins infections Diarrhea neutropenia, the client
Brand name: Special Precautions Drowsiness leucopenia, 2. Verify client’s
Ancef Action: Adult: 1 g given 30-60 Patient w/ history of Eosinophilia thrombocytopenia, identity with two
Cefazolin binds to 1 or min prior to surgery, hypersensitivity to Fainting thrombocythemia; identification
Usual dosage/ more of the penicillin- followed by 0.5-1 g penicillins, GI disease Fever transient elevation in markers
frequency: binding proteins (PBPs) during surgery for particularly colitis, Gas SGOT, SGPT and 3. Check and
500mg, 1g, 2g, 10g which inhibits the final lengthy procedures, seizure disorder. Renal Headache alkaline phosphatase review MAR
transpeptidation step of then 0.5-1 g 6-8 hrly impairment. Pregnancy Heartburn levels. The label on the
Usual route: peptidoglycan synthesis after surgery for 24 hr or and lactation. medication must
Parenteral, in bacterial cell wall, up to 5 days. All doses be checked for
Intraperitoneal thus inhibiting to be given by deep IM Serious interactions of name, dose,
(Pregnancy Category) biosynthesis and inj, slow IV inj over 3-5 cefazolin include: and route, and
arresting cell wall min, or intermittent or antithrombin alfa compared with
assembly resulting in continuous IV infusion. antithrombin III the MAR at
Drug order: bacterial cell death. argatroban three different
Cefazolin 500mg TIV BCG vaccine live times.
every 8hours ANST for References: bivalirudin 4. Explain and
3 doses Cunha J.P. 2021 RXList cholera vaccine review 10Rs of
medication to
the patient.
5. Review patient’s
VS and history
of anaphylactic
reactions
Vizconde, Ehreiz Raiden C. BSN2-A
Before Admnsitration:
1. Proper
handwashing
and position
patient
appropriately for
medication
administration.
2. Ensure proper
body mechanics
for health care
provider.
3. Position patient
safely and
appropriately
once medication
is administered.
4. Position patient
appropriately for
medication
administration.
5. Ensure proper
body mechanics
for health care
provider.
6. Do not admix
with
aminoglycoside
s in same
bottle/bag

Administration:
1. If administering
through a
running
intravenous,
observe for free
flow of IV
Vizconde, Ehreiz Raiden C. BSN2-A
solution.
2. If using a saline
lock, assess for
any occlusion
by ease of flush.

3. If using a CVC,
assess patency
and flush as
appropriate
before and after
medication:
refer to Policy.

4. Ensure the CVC

can be easily
flushed prior to
administering
medication with
a 10ml syringe
filled with 0.9%
Sodium
Chloride. Once
patency has
been confirmed
using a 10mL
flush
syringe,
administration of
the medication
can be given in
a syringe
appropriately
sized to
measure and
administer the
required dose.
Vizconde, Ehreiz Raiden C. BSN2-A
5. Attach
medication
syringe, inject at
correct rate.

6. Proper
handwashing
and observe
signs of
anaphylactic
shock

7. Retake patient’s
VS. Position
patient safely
and
appropriately
once medication
is administered.

8. On the
Medication
Administration
Record (or
appropriate
record) include
date, time,
name of drug,
dosage, route,
initials and co-
signer initials if
medication
requires an
independent
double check.

9. On flow
sheet/progress
Vizconde, Ehreiz Raiden C. BSN2-A
note include
rationale for
administration
and response.

MEDICATION Classification/ Action Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities
Classification: Intramuscular, In patients who have Fever, Nausea, Hypersensitivity Standard Procedure:
Generic name: Nonsteroidal Anti- Intravenous developed nasal polyps, Diarrhea, Headache, reactions (e.g. 1. Introduce self to
Ketorolac Inflammatory Agent angioedema, or Dizziness, Vertigo, bronchospasm); renal the client
(NSAID) Postoperative pain bronchospastic Tinnitus. papillary necrosis 2. Verify client’s
Brand name: Adult: Short-term reactions to other (prolonged use), acute identity with two
Toradol management of NSAIDs, active peptic renal failure, interstitial identification markers
Action: Inhibits moderate to severe ulcer disease, recent GI nephritis, nephrotic 3. Check and
prostaglandin synthesis acute cases: Initially, 10 bleeding or perforation, syndrome, new onset or review MAR
Usual dosage/ by decreasing the mg, followed by 10-30 patients with advanced exacerbation of The label on the
frequency: activity of the enzyme, mg 4-6 hourly as renal disease or risk of hypertension, Na and medication must be
I.V.: Initial: 30 mg, then cyclo-oxygenase, which needed; may also be renal failure, labor and fluid retention, checked for name,
15-30 mg every 6 hours
as needed for up to 5
results in decreased given as often as 2 delivery, nursing hyperkalaemia, dose, and route, and
days maximum; formation of hourly in the initial mothers, patients with compared with the MAR
maximum daily dose: prostaglandin postoperative period if hypersensitivity to at three different times.
120 mg for up to 5 days precursors necessary. Max: 90 mg ketorolac, aspirin, or 4. Explain and
total daily. In patients other NSAIDs, review 10Rs of
Reference: weighing <50 kg: Dose prophylaxis before medication to the
Watcha MF, Jones MB, reduction is required major surgery, patient.
Usual route: Lagueruela RG, et al, (Max: 60 mg daily). All suspected or confirmed 5. Review
IV, IM and Oral "Comparison of doses are given via cerebrovascular patient’s VS and history
Ketorolac and Morphine bolus IV inj over at least bleeding, hemorrhagic of anaphylactic
Drug order:
as Adjuvants During 15 seconds or slow IM diathesis, concurrent reactions
Ketorolac 30mg TIV
Pediatric Surgery," inj. Use the lowest ASA or other NSAIDs,
every 6 hours ANST
Anesthesiology, 2012, effective dose for the epidural or intrathecal Before Admnsitration:
76(3):368-72. shortest possible administration, 1. Proper
duration. Max treatment concomitant probenecid handwashing and
duration: 2 days. position patient
Convert to oral appropriately for
treatment once possible. medication
Dosage administration.
Vizconde, Ehreiz Raiden C. BSN2-A
recommendations may 2. Ensure proper
vary among countries body mechanics for
and individual products health care provider.
(refer to detailed product 3. Position patient
guideline). safely and appropriately
once medication is
administered.
4. Position patient
appropriately for
medication
administration.
5. Ensure proper
body mechanics for
health care provider.

Administration:
1. If administering
through a running
intravenous, observe for
free flow of IV solution.
2.
If using a saline lock,
assess for any occlusion
by ease of flush.

3. If using a CVC,
assess patency and
flush as appropriate
before and after
medication: refer to
Policy.

4. Ensure the CVC

can be easily flushed
prior to administering
medication with a 10ml
syringe
filled with 0.9% Sodium
Vizconde, Ehreiz Raiden C. BSN2-A
Chloride. Once patency
has been confirmed
using a 10mL flush
syringe, administration
of the medication can be
given in a syringe
appropriately sized to
measure and administer
the required dose.

5. Attach
medication syringe,
inject at correct rate.

6. Proper
handwashing and
observe signs of
anaphylactic shock

7. Retake patient’s
VS. Position patient
safely and appropriately
once medication is
administered.

8. On the
Medication
Administration Record
(or appropriate record)
include date, time, name
of drug, dosage, route,
initials and co-signer
initials if medication
requires an independent
double check.

9. On flow
Vizconde, Ehreiz Raiden C. BSN2-A
sheet/progress note
include rationale for
administration and client
response
10. Monitor for
signs of pain relief, such
as an increased appetite
and activity

Medication Classification/ Action Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities
Classification: CEFTIN Axetil tablets Hypersensitivity to Allergic reactions Stevens-Johnson Standard Procedure:
Generic name: Cephalosporins, 2nd are indicated for the cefuroxime or to other Confusion syndrome, erythema 1. Introduce self to
Cefuroxime generation. treatment of adult cephalosporins. Diarrhea multiforme, toxic the client
patients and pediatric Drowsiness epidermal necrolysis, 2. Verify client’s
Action:Cefuroxime patients (aged 13 and Eosinophilia serum sickness-like
Brand name: identity with two
inhibits bacterial cell older) with Fainting reactions, angioedema;
Axetil wall synthesis by uncomplicated Fever mild to moderate identification
binding to one 1 or more gonorrhea, urethral and Gas hearing loss (childn); markers
Usual dosage/ of the penicillin-binding endocervical, caused by Headache nausea, vomiting, 3. Check and
frequency: proteins (PBPs) which in penicillinase producing Heartburn gagging, epigastric review MAR.
Adult: As cefuroxime turn inhibit the final and non-penicillinase- burning, The label on the
axetil: 250 or 500 mg 12 transpeptidation step of producing susceptible
hourly for 7-10 days. medication
peptidoglycan synthesis strains of Neisseria
in bacterial cell walls, must be
gonorrhoeae and
thus inhibiting cell wall uncomplicated checked for
Usual route: biosynthesis and name, dose,
gonorrhea, rectal, in
IV, IM, Oral, arresting cell wall and route, and
females, caused by non-
Suppositories assembly resulting in penicillinase-producing compared with
bacterial cell death. susceptible strains of the MAR at
Drug order:
Neisseria gonorrhoeae. three different
Cefuroxime 500mg p.o.
Vizconde, Ehreiz Raiden C. BSN2-A
TID References: times.
Anon. Cefuroxime. 4. Explain and
Lexicomp Online. review 10Rs of
Hudson, Ohio. Wolters medication to
Kluwer Clinical Drug
Information, Inc. the patient.
https://online.lexi.com. 5. Review
Accessed 14/10/2014. patient’s VS
and history of
anaphylactic
reactions

Before Admnsitration:
1. Proper
handwashing and
position patient
appropriately for
medication
administration.
2. Ensure proper
body mechanics for
health care provider.
3. Position patient
safely and appropriately
once medication is
administered.
4. Position patient
appropriately for
medication
administration.
5. Ensure proper
body mechanics for
health care provider.
6. Place all
medications that patient
will receive in one cup,
except medications that
require pre-assessment
Vizconde, Ehreiz Raiden C. BSN2-A
(e.g., blood pressure or
pulse rate). Place these
in a separate cup and
keep wrapper intact.
7. Do not mix with
aminoglycosides in
same bottle/bag; obtain
specimens for culture
and sensitivity prior to
the first dose

Administration:
1. Administer
medication
orally as
prescribed.
Tablets: place
in mouth and
swallow using
water or other
oral fluids.
2. Post-medication
safety check
3. Stay with
patient until all
medications are
swallowed or
dissolved.
4. Perform post
assessments
and/or vital
signs if
applicable.
5. Sign MAR and
place in
appropriate
chart.
6. Perform hand
Vizconde, Ehreiz Raiden C. BSN2-A
hygiene.
7. Document any
additional
information,
such as patient
education,
reasons why
medication not
administered,
and adverse
effects, as per
agency policy.
8. Return within
appropriate time
to evaluate
patient’s VS
and response to
the medications
and to check for
possible
adverse effects
9. On the
Medication
Administration
Record (or
appropriate
record) include
date, time,
name of drug,
dosage, route,
initials and co-
signer initials if
medication
requires an
independent
double check.
10. On flow
sheet/progress
Vizconde, Ehreiz Raiden C. BSN2-A
note include
rationale for
administration
and client
response

Medication Classification/ Action
Classification:
Generic name: Nonsteroidal Anti-
Celecoxib Inflammatory Drugs
(NSAIDS)
Brand name:
Celecoxx
Action:
Celecoxib, an NSAID,
Usual dosage/ is a selective
frequency: Adult: cyclooxygenase-2
Initially, 400 mg followed (COX-2) inhibitor
by additional dose of primarily responsible for
200 mg if necessary on inhibition of
day 1. Subsequently, prostaglandin synthesis.
200 mg bid as needed. It exhibits anti-
inflammatory, analgesic
Usual route: and antipyretic activities.
Oral
References:
Drug order: Celecoxib, an NSAID, is
Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities
For the management of Hypersensitivity Allergic reactions Significant: Fluid Standard Procedure:
acute pain in adults (including urticaria, Confusion retention, oedema, 1. Introduce self to
asthma, angioneurotic Diarrhea hypertension, renal the client
edema) to celecoxib and Drowsiness papillary necrosis 2. Verify client’s
other NSAIDs, aspirin or Eosinophilia (prolonged use). identity with two
sulfonamides. Active Fainting Blood and lymphatic identification markers
peptic ulceration or Fever system disorders: 3. Check and
gastrointestinal Gas Anaemia. review MAR. The label
bleeding, inflammatory Headache Cardiac disorders: on the medication must
bowel disease, Heartburn Angina pectoris. be checked for name,
Gastrointestinal dose, and route, and
disorders: Nausea, compared with the MAR
abdominal pain, at three different times.
diarrhoea, dyspepsia, 4. Explain and
flatulence, vomiting, review 10Rs of
dysphagia, GERD, medication to the
irritable bowel patient.
syndrome. 5. Review
patient’s VS and history
of anaphylactic
Vizconde, Ehreiz Raiden C. BSN2-A
Celecoxib 200mg p.o. a selective
BID for pain cyclooxygenase-2
(COX-2) inhibitor
primarily responsible for
inhibition of
prostaglandin synthesis.
It exhibits anti-
inflammatory, analgesic
and antipyretic activities.
Pregnancy Category reactions
(US FDA)
PO: C (prior to 30 Before Administration:
weeks gestation), D 1. Position the
(starting at 30 weeks patient appropriately for
gestation), Z (NSAIDs medication
caused foetal ductus administration.
arteriosus premature 2. Ensure proper
closure, foetal renal body mechanics for
impairment and health care provider.
persistent pulmonary 3. Position patient
hypertension. Avoid safely and appropriately
near term, else use once medication is
lowest dose for shortest administered.
time. 4. Position patient
appropriately for
medication
administration.
5. Ensure proper
body mechanics for
health care provider.
6. Place all
medications that patient
will receive in one cup,
except medications that
require pre-assessment
(e.g., blood pressure or
pulse rate). Place these
in a separate cup and
keep wrapper intact.
Administration:
1. Administer
medication orally as
prescribed.
Tablets: place in mouth
and swallow using water
or other oral fluids.
Vizconde, Ehreiz Raiden C. BSN2-A
2. Post-medication
safety check
3. Stay with
patient until all
medications are
swallowed or dissolved.
4. Perform post
assessments and/or
vital signs if applicable.
5. Sign MAR and
place in appropriate
chart.
6. Perform hand
hygiene.
7. Document any
additional information,
such as patient
education, reasons why
medication not
administered, and
adverse effects, as per
agency policy.
8. Return within
appropriate time to
evaluate patient’s VS
and response to the
medications and to
check for possible
adverse effects
9. On the
Medication
Administration Record
(or appropriate record)
include date, time, name
of drug, dosage, route,
initials and co-signer
initials if medication
requires an independent
Vizconde, Ehreiz Raiden C. BSN2-A
double check.
10. On flow
sheet/progress note
include rationale for
administration and client
response

Medication Classification/ Action Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities
Classification: Prevention and Haemochromatosis, Fever, Nausea, Gastrointestinal Standard Procedure:
Generic name: Vitamins and Minerals (Pre treatment of iron other iron overload Diarrhea, Headache, disorders: 1. Introduce self to
Ferrous Sulfate and Postnatal)/Antiemetics deficiency anemias syndromes. Blood Dizziness, Vertigo, Gastrointestinal the client
disorders (e.g. Tinnitus. irritation, nausea, 2. Verify client’s
Brand name: paroxysmal nocturnal vomiting, epigastric identity with two
Ferglobin Action: haemoglobinuria, pain, diarrhoea, identification markers
Ferrous sulfate facilitates haemolytic anaemia, constipation, 3. Check and
Usual dosage/ oxygen transport via Hb. It is haemosiderosis, other blackening of stool, review MAR. The label
frequency: used as iron source as it anaemias); active peptic tooth discolouration, on the medication must
Adult: As replaces iron found in Hb, ulcer, regional enteritis abdominal discomfort. be checked for name,
elemental iron: myoglobin and other and ulcerative colitis. Immune system dose, and route, and
Treatment: 65-200 enzymes. Patient receiving disorders: compared with the MAR
mg daily, in 2-3 frequent blood Hypersensitivity. at three different times.
divided doses. transfusions. 4. Explain and
Prevention: 65 mg References: Concomitant parenteral review 10Rs of
daily. Buckingham R (ed). Ferrous iron therapy. medication to the
Sulfate. Martindale: The patient.
Complete Drug Reference 5. Review patient’s
Usual route: [online]. VS and history of
Oral London. anaphylactic reactions
Pharmaceutical Press.
Drug order: https://www.medicines Before Administration:
Vizconde, Ehreiz Raiden C. BSN2-A
Ferrous Sulfate complete.com. Accessed 1. Proper
Tablet OD once on 17/12/2019. Handwashing and
diet. position the patient
appropriately for
medication
administration.
2. Ensure proper
body mechanics for
health care provider.
3. Position patient
safely and appropriately
once medication is
administered.
4. Position patient
appropriately for
medication
administration.
5. Ensure proper
body mechanics for
health care provider.
6. Place all
medications that patient
will receive in one cup,
except medications that
require pre-assessment
(e.g., blood pressure or
pulse rate). Place these
in a separate cup and
keep wrapper intact.
7. Administer 2
hours before or 4 hours
after antacids
8. Monitor serum
iron, total iron binding
capacity, reticulocyte
count, hemoglobin.

Administration:
Vizconde, Ehreiz Raiden C. BSN2-A
1. Administer
medication orally as
prescribed.
Tablets: place in mouth
and swallow using water
or other oral fluids.
2. Post-medication
safety check
3. Stay with patient
until all medications are
swallowed or dissolved.
4. Perform post
assessments and/or vital
signs if applicable.
5. Sign MAR and
place in appropriate
chart.
6. Perform hand
hygiene.
7. Document any
additional information,
such as patient
education, reasons why
medication not
administered, and
adverse effects, as per
agency policy.
8. Return within
appropriate time to
evaluate patient’s VS
and response to the
medications and to
check for possible
adverse effects
9. On the
Medication
Administration Record
(or appropriate record)
Vizconde, Ehreiz Raiden C. BSN2-A
include date, time, name
of drug, dosage, route,
initials and co-signer
initials if medication
requires an independent
double check.
10. On flow
sheet/progress note
include rationale for
administration and client
response

Medication Classification/ Action Indications Contraindications Side Effects Adverse Effects Nursing Responsibilities
Generic name: Classification: Treatment of Pre-existing blood Fatigue, lethargy, fever, Acute renal failure, bone Standard Procedure:
Methotrexate Cytotoxic Chemotherapy trophoblastic dyscrasias (e.g. bone chills, wound healing marrow suppression 1. Introduce self to
/ Immunosuppressants neoplasms; leukemias; marrow hypoplasia, impairment, asthenia. (e.g. anaemia, the client
Brand name: psoriasis; rheumatoid leucopenia, pancytopenia, 2. Verify client’s
Alltrex Action: arthritis; breast, head thrombocytopenia, neutropenia,
identity with two
Methotrexate is a folate and neck, and lung significant anaemia), leucopenia,
antimetabolite that carcinomas; active infection, thrombocytopenia); identification
Usual dosage/ competitively inhibits the osteosarcoma; immunodeficiency gastrointestinal toxicity markers
frequency: dihydrofolate reductase sarcomas; carcinoma of syndrome (with overt or including ulcerative 3. Check and
Adult: 15-30 mg daily for and prevents formation gastric, esophagus, laboratory evidence), stomatitis and diarrhea; review MAR
a 5-day course, may of tetrahydrofolate, testes; lymphomas known active malignant lymphomas The label on the
repeat course for 3-5 which is necessary for gastrointestinal ulcer (low dose), impairment
times as necessary with thymidylate and purine medication
disease, alcoholism. of fertility, oligospermia,
at least 1 week rest formation, thus must be
menstrual dysfunction,
periods between preventing DNA checked for
courses until toxicity synthesis, repair and name, dose,
subsides. cellular replication. It is and route, and
Vizconde, Ehreiz Raiden C. BSN2-A
most active in the S- compared with
Usual route: phase of the cell cycle. the MAR at
Parenteral, IV, Its mechanism of action three different
Intratechal, Oral, in the management of
times.
rheumatoid arthritis and
Drug order: juvenile idiopathic 4. Explain and
Methatrexate 25mg IM arthritis is still unknown review 10Rs of
but may be due to its medication to
immunosuppressive the patient.
effect. In psoriasis, it is 5. Review
thought to target rapidly patient’s VS
proliferating epithelial
and history of
cells in the skin.
anaphylactic
References: reaction
Buckingham R (ed).
Methotrexate. Before Administration:
Martindale: The 1. Proper
Complete Drug handwashing
Reference [online]. and position
London. Pharmaceutical patient
Press. https://www. appropriately for
medicinescomplete.com medication
. Accessed 08/04/2020. administration.
2. Ensure proper
body mechanics
for health care
provider.
3. Position patient
safely and
appropriately
once
medication is
administered.
4. Position patient
appropriately for
medication
administration.
Vizconde, Ehreiz Raiden C. BSN2-A
5. Ensure proper
body mechanics
for health care
provider.

Administration:

1. Prepare the
medication
accordingly and
put it into the
syringe.

2. Attach the new

needle into the
syringe.

3. The site should

be free of
bumps and
scars.
4. Clean the site
with an alcohol
pad. Allow the
alcohol to dry.
Do not use a
blower or fan to
quicken the
drying process.

5. Spread the skin

with your
fingers and
inject the
needle straight
down in a dart-
like motion all
the way.
Vizconde, Ehreiz Raiden C. BSN2-A

6. Pull back on the

plunger a little.
If you see blood
enter the
syringe, pull the
needle out a
little and inject
the medication.
If you do not
see blood,
simply inject.

7. Pull the needle

out and dispose
of properly in a
sharps
container. Do
not put medical
or sharp waste
in the regular
garbage.

8. Use the gauze

to dab up any
blood, if
necessary, and
cover with a
bandage.

9. Perform hand
hygiene.

10. Sign MAR and

place in
appropriate
chart
Vizconde, Ehreiz Raiden C. BSN2-A
11. Document any
additional
information,
such as patient
education,
reasons why
medication not
administered,
and adverse
effects, as per
agency policy.

12. Return within

appropriate time
to evaluate
patient’s VS
and response to
the medications
and to check for
possible
adverse effects

13. On the
Medication
Administration
Record (or
appropriate
record) include
date, time,
name of drug,
dosage, route,
initials and co-
signer initials if
medication
requires an
independent
double check.
Vizconde, Ehreiz Raiden C. BSN2-A
14. On flow
sheet/progress
note include
rationale for
administration
and client
response